THE WHAT? Johnson & Johnson (J&J) has reported 2021 Q4 sales of US$24.8 billion, a growth of 10.4 percent, with full year 2021 sales reaching US$93.8 billion, up 13.6 percent.
THE DETAILS J&J’s Consumer Health arm saw a reported Q4 rise of 1.1 percent and a full year growth of 4.1 percent.
This was primarily driven by OTC products such as Tylenol analgesics and digestive health. As well as Neutrogena and Aveeno products in skin health and beauty, whose growth was attributed to COVID-19 market recovery.
Regionally, the U.S. saw a 3 percent reported rise in Q4, while International rose 18.5 percent and Worldwide grew 10.4 percent.
THE WHY? Joaquin Duato, Chief Executive Officer, said, “Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers.
“Given our strong results, financial profile, and innovative pipeline we are well positioned for success in 2022 and beyond.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
